Skip to main content Scroll Top
Alzheimer’s disease and gut microbiota: a potential for prevention and treatment
Most Viewed Posts
Clear Filters
Alzheimer’s: REGEnLIFE opens two new centres in Paris for its clinical trial
Alzheimer’s: REGEnLIFE opens two new centres in Paris for its clinical trial
15 March 2026
Alzheimer’s disease: an innovative non-drug trial gets underway in Toulouse
Alzheimer’s disease: an innovative non-drug trial gets underway in Toulouse
25 September 2023
A promising new treatment for concussion and Alzheimer’s victims?
A promising new treatment for concussion and Alzheimer’s victims?
26 September 2024
2 July 2019

Alzheimer’s disease and gut microbiota: a potential for prevention and treatment

Clinical Trials on Alzheimer’s Disease Asia (CTAD Asia) 2019, Beijing
Read the article

Jacques Touchon, MD, PhD, Laura Auboyer, PhD, Johann Meunier, PhD, Laura Ceolin, PhD, François J. Roman, PhD, Rémy Burcelin, PhD, Guillaume Blivet, MS. Late Breaking Oral Communication.

Share this article